1. Home
  2. EXG vs HAE Comparison

EXG vs HAE Comparison

Compare EXG & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Tax-Managed Global Diversified Equity Income Fund of Beneficial Interest

EXG

Eaton Vance Tax-Managed Global Diversified Equity Income Fund of Beneficial Interest

HOLD

Current Price

$8.64

Market Cap

2.7B

Sector

Finance

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$58.78

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXG
HAE
Founded
N/A
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.8B
IPO Year
2006
1996

Fundamental Metrics

Financial Performance
Metric
EXG
HAE
Price
$8.64
$58.78
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$85.38
AVG Volume (30 Days)
518.3K
619.6K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
44.54
EPS
N/A
2.46
Revenue
N/A
$910,373,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$5.31
P/E Ratio
N/A
$23.79
Revenue Growth
N/A
N/A
52 Week Low
$6.74
$47.32
52 Week High
$9.78
$87.32

Technical Indicators

Market Signals
Indicator
EXG
HAE
Relative Strength Index (RSI) 21.76 34.23
Support Level $8.49 $48.47
Resistance Level $8.89 $66.86
Average True Range (ATR) 0.13 1.53
MACD -0.06 -0.14
Stochastic Oscillator 11.35 10.70

Price Performance

Historical Comparison
EXG
HAE

About EXG Eaton Vance Tax-Managed Global Diversified Equity Income Fund of Beneficial Interest

Eaton Vance Tax-Mgd Glbl Div Eq Inc is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary focus of the fund is capital appreciation. It invests in a diversified portfolio of domestic and foreign common stocks, emphasizing dividend-paying stocks. It writes call options on one or more U.S. and foreign indices for a portion of the value of its common stock portfolio to generate current cash flow from the options premium received. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, consumable fuels, and other sectors.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: